Olema Pharmaceuticals (OLMA) Operating Leases (2021 - 2025)

Olema Pharmaceuticals (OLMA) has 5 years of Operating Leases data on file, last reported at $69000.0 in Q4 2025.

• Operating Leases for Q4 2025 came in at $69000.0, down 73.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $69000.0 (down 73.15% YoY), and the FY2025 annual result was $69000.0, down 73.15% from the prior year.
• Operating Leases declined to $69000.0 in Q4 2025 per OLMA's latest filing, from $310000.0 in the prior quarter.
• Over five years, Operating Leases peaked at $2.4 million in Q4 2021 and troughed at $69000.0 in Q4 2025.
• A 5-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2025: Operating Leases slipped 2.69% in 2023, then plunged 89.32% in 2025.
• A 5-year view of Operating Leases shows it stood at $2.4 million in 2021, then sank by 34.27% to $1.5 million in 2022, then slipped by 7.81% to $1.4 million in 2023, then tumbled by 82.02% to $257000.0 in 2024, then slumped by 73.15% to $69000.0 in 2025.
• Business Quant data shows OLMA's Operating Leases at $69000.0 in Q4 2025, $310000.0 in Q3 2025, and $602000.0 in Q2 2025.